Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 81-87, March 2009

Fever of Unknown Origin

  • Chantal P. Bleeker-Rovers, MD, PhD

      Affiliations

    • Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
    • Nijmegen Institute for Infection, Inflammation and Immunity (N4I), Nijmegen, the Netherlands
    • Corresponding Author InformationAddress reprint requests to Chantal P. Bleeker-Rovers, MD, PhD, Department of General Internal Medicine 463, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands
  • ,
  • Jos W.M. van der Meer, MD, PhD

      Affiliations

    • Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
    • Nijmegen Institute for Infection, Inflammation and Immunity (N4I), Nijmegen, the Netherlands
  • ,
  • Wim J.G. Oyen, MD, PhD

      Affiliations

    • Nijmegen Institute for Infection, Inflammation and Immunity (N4I), Nijmegen, the Netherlands
    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

Fever of unknown origin (FUO) often is defined as a fever greater than 38.3°C on several occasions during at least 3 weeks with uncertain diagnosis after a number of obligatory tests. In general, infection accounts for approximately one-fourth of cases of FUO, followed by neoplasm and noninfectious inflammatory diseases. No diagnosis is reached in up to 50% of cases. Scintigraphic methods, such as 67Ga-citrate, labeled leukocytes, and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET), are often used in the diagnosis of FUO. In FUO, FDG-PET appears to be of great advantage because malignancy, inflammation, and infection can be detected. FDG-PET does not seem to contribute to a final diagnosis in patients with normal erythrocyte sedimentation rate and C-reactive protein. Image fusion combining PET and computed tomography facilitates anatomical localization of increased FDG uptake and better guiding for further diagnostic tests to achieve a final diagnosis. In conclusion, the body of evidence on the utility of FDG-PET in patients with FUO is growing and FDG-PET will probably become the preferred diagnostic procedure, especially when a definite diagnosis cannot easily be achieved. Because of favorable characteristics of FDG-PET, conventional scintigraphic techniques may be replaced by FDG-PET in institutions in which PET is available.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(08)00119-0

doi:10.1053/j.semnuclmed.2008.10.002

Seminars in Nuclear Medicine
Volume 39, Issue 2 , Pages 81-87, March 2009